138 related articles for article (PubMed ID: 25480503)
1. Flavoxate in urogynecology: an old drug revisited.
Zor M; Aydur E; Dmochowski RR
Int Urogynecol J; 2015 Jul; 26(7):959-66. PubMed ID: 25480503
[TBL] [Abstract][Full Text] [Related]
2. Anticholinergic drugs versus other medications for overactive bladder syndrome in adults.
Roxburgh C; Cook J; Dublin N
Cochrane Database Syst Rev; 2007 Jul; (3):CD003190. PubMed ID: 17636716
[TBL] [Abstract][Full Text] [Related]
3. Flavoxate in the symptomatic treatment of overactive bladder: a meta-analysis.
Sweeney P; Mutambirwa S; Van An N; Sharma JB; Vanamail P
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3703-12. PubMed ID: 27649675
[TBL] [Abstract][Full Text] [Related]
4. Anticholinergic drugs versus other medications for overactive bladder syndrome in adults.
Roxburgh C; Cook J; Dublin N
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003190. PubMed ID: 17943782
[TBL] [Abstract][Full Text] [Related]
5. Flavoxate: present and future.
Arcaniolo D; Conquy S; Tarcan T
Eur Rev Med Pharmacol Sci; 2015; 19(5):719-31. PubMed ID: 25807422
[TBL] [Abstract][Full Text] [Related]
6. An overview on mixed action drugs for the treatment of overactive bladder and detrusor overactivity.
Asimakopoulos AD; Cerruto MA; Del Popolo G; La Martina M; Artibani W; Carone R; Finazzi-Agrò E
Urol Int; 2012; 89(3):259-69. PubMed ID: 22777274
[TBL] [Abstract][Full Text] [Related]
7. Using flavoxate as primary medication for patients suffering from urge symptomatology.
Fehrmann-Zumpe P; Karbe K; Blessman G
Int Urogynecol J Pelvic Floor Dysfunct; 1999; 10(2):91-5. PubMed ID: 10384969
[TBL] [Abstract][Full Text] [Related]
8. Flavoxate, a drug with smooth muscle relaxing activity.
Ruffmann R; Sartani A
Drugs Exp Clin Res; 1987; 13(1):57-62. PubMed ID: 3595445
[TBL] [Abstract][Full Text] [Related]
9. A review of flavoxate hydrochloride in the treatment of urge incontinence.
Ruffmann R
J Int Med Res; 1988; 16(5):317-30. PubMed ID: 2461883
[TBL] [Abstract][Full Text] [Related]
10. Clinical guidelines for overactive bladder.
Yamaguchi O; Nishizawa O; Takeda M; Yokoyama O; Homma Y; Kakizaki H; Obara K; Gotoh M; Igawa Y; Seki N; Yoshida M;
Int J Urol; 2009 Feb; 16(2):126-42. PubMed ID: 19228224
[No Abstract] [Full Text] [Related]
11. Motor urge incontinence: diagnosis and treatment.
Gaudenz R; Weil A
Urol Int; 1980; 35(1):1-12. PubMed ID: 7361347
[TBL] [Abstract][Full Text] [Related]
12. [Clinical effects of terodiline hydrochloride on urinary frequency and sense of residual urine--a double blind clinical trial using flavoxate hydrochloride as a control].
Ogawa A; Shimazaki J; Mitsuya H; Miyazaki S; Kurita T
Hinyokika Kiyo; 1988 Apr; 34(4):739-53. PubMed ID: 3041785
[TBL] [Abstract][Full Text] [Related]
13. Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience.
Wagg A; Compion G; Fahey A; Siddiqui E
BJU Int; 2012 Dec; 110(11):1767-74. PubMed ID: 22409769
[TBL] [Abstract][Full Text] [Related]
14. Comparison of flavoxate hydrochloride in daily dosages of 600 versus 1200 mg for the treatment of urgency and urge incontinence.
Milani R; Scalambrino S; Carrera S; Pezzoli P; Ruffmann R
J Int Med Res; 1988; 16(3):244-8. PubMed ID: 3044876
[TBL] [Abstract][Full Text] [Related]
15. Treatment of motor urge incontinence with clenbuterol and flavoxate hydrochloride.
Grüneberger A
Br J Obstet Gynaecol; 1984 Mar; 91(3):275-8. PubMed ID: 6367811
[TBL] [Abstract][Full Text] [Related]
16. Trospium chloride treatment of overactive bladder.
Biastre K; Burnakis T
Ann Pharmacother; 2009 Feb; 43(2):283-95. PubMed ID: 19193592
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.
Schaefer W
Int J Urol; 2007 Jul; 14(7):670; author reply 670-1. PubMed ID: 17645621
[No Abstract] [Full Text] [Related]
18. Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladder.
Anderson RU; MacDiarmid S; Kell S; Barada JH; Serels S; Goldberg RP
Int Urogynecol J Pelvic Floor Dysfunct; 2006 Sep; 17(5):502-11. PubMed ID: 16724169
[TBL] [Abstract][Full Text] [Related]
19. Drug eruption due to flavoxate hydrochloride.
Enomoto U; Ohnishi Y; Kimura M; Kawada A; Ishibashi A
Contact Dermatitis; 1999 Jun; 40(6):337-8. PubMed ID: 10385348
[No Abstract] [Full Text] [Related]
20. Anticholinergic therapy: do the patients take the pills prescribed?
Jundt K; Schreyer K; Friese K; Peschers U
Arch Gynecol Obstet; 2011 Sep; 284(3):663-6. PubMed ID: 21046135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
